Interventional Pulmonology
In this year-end review, we are pleased to share personal highlights from members of the touchRESPIRATORY Editorial Board and this year's Future Leaders cohort, whose perspectives offer a window into the innovations that have most influenced clinical practice and research over the past 12 months. Their reflections capture not only the momentum of 2025, but also the promise of what lies ahead as the field continues to evolve.
As touchRESPIRATORY approaches 10 years of providing education for busy respiratory specialists, we are looking to the future—and it certainly looks bright!
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
Lung cancer remains the leading cause of cancer-related death.1Â However, five-year survival in lung cancer varies greatly based on the stage of the disease at diagnosis.2Â Early lung cancer diagnosis through screening with low-dose computed tomography (CT) demonstrated a 20% reduction ...
With lung cancer as the leading cause of cancer-related death worldwide and with the risk of complications from invasive surgeries, there is a need for minimally invasive ablative therapies for the treatment of lung tumours. It was a pleasure to ...
We caught up with Prof. Frank Sciurba (University of Pittsburgh, Pittsburgh, PA, USA) to discuss the 2 year findings from a US feasibility study of bronchial rheoplasty for chronic bronchitis and to learn more around the upcoming advances in chronic bronchitis. ...
We were delighted to catch up with Mr Alan Kirk (Golden Jubilee National Hospital, West Dunbartonshire, Scotland, UK) to discuss the 24-month follow-up to the TRANSFORM study, investigating endobronchial valve treatment for patients with severe heterogeneous emphysema. The abstract ‘Durability ...
Welcome to the latest edition of US Respiratory & Pulmonary Diseases, which aims to provide insightful and topical articles relevant to the everyday practice of busy physicians. COVID-19 continues to dominate headlines worldwide and is the focus of several of ...
At ERS 2019 in Madrid, we were joined by some of the top respiratory experts from around the world. Here, they share their highlights from this year's congress. touchRESPIRATORY.com is an independent information resource supporting physicians, clinicians and leading industry ...
At the 2019 ATS conference in Dallas, TX, USA, Frank Sciurba (University of Pittsburgh Medical Centre, Pittsburgh, PA, USA) discusses the challenges faced by patients with heterogeneous emphysema with negative collateral ventilation (CV) status and the potential of the Zephyr Valve ...
Lung diseases are highly prevalent and their early diagnosis is essential for successful treatment. Noninvasive imaging techniques are an important component of the diagnostic process for lung diseases and can also provide important information in terms of prognosis, as well ...
Lung, pulmonary, or broncholpulmonary sequestration is a congenital disorder in which tissue that develops into lung parenchyma is not attached to the bronchial system.1 Blood supply originates from the aorta or various peripheral arteries.1,2 It is also referred to as ...
Assessment of peripheral pulmonary nodules and mediastinal lymph nodes is critical in the diagnosis and staging of lung cancer, which is the leading cause of cancer death worldwide.1,2 Endobronchial ultrasound (EBUS) continues to evolve, allowing clinicians the ability to evaluate ...
Tube thoracostomy (chest tube placement) is a common procedure used in pathologic conditions to drain the pleural space of air (pneumothorax), blood (hemothorax), serum (pleural effusion), lymph (chylothorax), pus (empyema), or a combination of these.1 In these instances, when an ...
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
